Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EMPAGLIFLOZIN Cause Cystitis haemorrhagic? 8 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Cystitis haemorrhagic have been filed in association with EMPAGLIFLOZIN (Jardiance). This represents 0.0% of all adverse event reports for EMPAGLIFLOZIN.

8
Reports of Cystitis haemorrhagic with EMPAGLIFLOZIN
0.0%
of all EMPAGLIFLOZIN reports
0
Deaths
4
Hospitalizations

How Dangerous Is Cystitis haemorrhagic From EMPAGLIFLOZIN?

Of the 8 reports, 4 (50.0%) required hospitalization, and 1 (12.5%) were considered life-threatening.

Is Cystitis haemorrhagic Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EMPAGLIFLOZIN. However, 8 reports have been filed with the FAERS database.

What Other Side Effects Does EMPAGLIFLOZIN Cause?

Diabetic ketoacidosis (3,644) Fungal infection (1,941) Blood glucose increased (1,797) Euglycaemic diabetic ketoacidosis (1,769) Weight decreased (1,661) Urinary tract infection (1,439) Ketoacidosis (1,411) Dizziness (1,372) Nausea (1,333) Vomiting (1,201)

What Other Drugs Cause Cystitis haemorrhagic?

CYCLOPHOSPHAMIDE (1,036) CYCLOSPORINE (591) MYCOPHENOLATE MOFETIL (476) METHOTREXATE (413) FLUDARABINE (386) BUSULFAN (336) TACROLIMUS (336) MESNA (294) LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN (289) RITUXIMAB (261)

Which EMPAGLIFLOZIN Alternatives Have Lower Cystitis haemorrhagic Risk?

EMPAGLIFLOZIN vs EMPAGLIFLOZIN\LINAGLIPTIN EMPAGLIFLOZIN vs EMPAGLIFLOZIN\LINAGLIPTIN\METFORMIN EMPAGLIFLOZIN vs EMPAGLIFLOZIN\METFORMIN EMPAGLIFLOZIN vs EMSAM EMPAGLIFLOZIN vs EMTRICITABINE

Related Pages

EMPAGLIFLOZIN Full Profile All Cystitis haemorrhagic Reports All Drugs Causing Cystitis haemorrhagic EMPAGLIFLOZIN Demographics